Wolfgang Knauf Selected Research

Wolfgang Knauf Research Topics

Disease

12	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2024 - 10/2003
9	Multiple Myeloma 11/2022 - 06/2012
5	Neoplasms (Cancer) 03/2024 - 10/2003
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2013 - 09/2004
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 05/2007
2	B-Cell Lymphoma (Lymphoma, B Cell) 11/2019 - 01/2013
2	Pathologic Complete Response 01/2018 - 07/2010
2	Thrombocytopenia (Thrombopenia) 05/2013 - 12/2004
2	Hematologic Neoplasms (Hematological Malignancy) 05/2013 - 07/2010
2	Lymphoma (Lymphomas) 01/2013 - 09/2004
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2023
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2023
1	Enteritis 11/2022
1	Heart Arrest (Cardiac Arrest) 11/2022
1	Septic Shock (Toxic Shock Syndrome) 11/2022
1	Residual Neoplasm 11/2022
1	Renal Insufficiency (Renal Failure) 11/2022
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Leiomyosarcoma 01/2018
1	Chromosome Aberrations (Chromosome Abnormalities) 06/2017
1	Drug-Related Side Effects and Adverse Reactions 01/2015
1	Leukopenia 02/2009
1	Infections 08/2005
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2005
1	Anemia 12/2004
1	Lymphadenopathy 12/2004
1	Splenomegaly 12/2004
1	Hepatomegaly 12/2004
1	Neurologic Manifestations (Neurological Manifestations) 10/2003
1	Progressive Multifocal Leukoencephalopathy 10/2003

Drug/Important Bio-Agent (IBA)

7	Bendamustine Hydrochloride FDA Link 04/2024 - 09/2004
6	Dexamethasone (Maxidex)FDA LinkGeneric 11/2022 - 06/2012
5	Bortezomib (Velcade)FDA Link 11/2022 - 01/2015
5	fludarabineIBA 01/2020 - 10/2003
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 06/2012
3	obinutuzumabIBA 04/2024 - 01/2018
3	Rituximab (Mabthera)FDA Link 02/2023 - 05/2007
3	Lenalidomide (CC 5013)FDA Link 11/2022 - 03/2017
3	Prednisone (Sone)FDA LinkGeneric 08/2020 - 01/2015
2	idelalisibIBA 04/2024 - 01/2022
2	Melphalan (Alkeran)FDA LinkGeneric 11/2022 - 01/2015
2	Drug CombinationsIBA 08/2020 - 09/2004
2	Vincristine (Oncovin)FDA LinkGeneric 11/2019 - 06/2012
2	Chlorambucil (Leukeran)FDA Link 05/2013 - 05/2007
1	Biosimilar PharmaceuticalsIBA 02/2023
1	CT-P10IBA 02/2023
1	Monoclonal AntibodiesIBA 11/2022
1	isatuximabIBA 11/2022
1	pomalidomideIBA 02/2022
1	Immunologic Factors (Immunomodulators)IBA 02/2022
1	Cytostatic AgentsIBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2019
1	TrabectedinIBA 01/2018
1	Alkylating AgentsIBA 05/2013
1	Vinorelbine (Navelbine)FDA LinkGeneric 06/2012
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 06/2012
1	Thalidomide (Thalomid)FDA Link 06/2012
1	treosulfanIBA 07/2010
1	Stem Cell FactorIBA 10/2008
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2008
1	ancestimIBA 10/2008
1	Etodolac (Lodine)FDA LinkGeneric 04/2008
1	Prednisolone (Predate)FDA LinkGeneric 05/2007
1	Mitoxantrone (Novantrone)FDA LinkGeneric 05/2007
1	InterferonsIBA 05/2007
1	Basiliximab FDA Link 08/2005
1	SteroidsIBA 08/2005
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 08/2005
1	Alemtuzumab (Campath)FDA Link 12/2004
1	Cidofovir (Vistide)FDA Link 10/2003
1	A-factor (Streptomyces)IBA 10/2003

Therapy/Procedure

9	Therapeutics 11/2022 - 10/2003
6	Stem Cell Transplantation 11/2022 - 12/2004
5	Drug Therapy (Chemotherapy) 01/2020 - 12/2004
1	Radiotherapy 03/2024
1	Operative Surgical Procedures 03/2024
1	Transplantation 11/2022
1	Duration of Therapy 09/2020
1	Autologous Transplantation 06/2017
1	Hematopoietic Stem Cell Transplantation 07/2010
1	Remission Induction 12/2004